Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Harvard Business School
Cerilliant
Fuji
US Department of Justice
Express Scripts
Mallinckrodt
Deloitte

Generated: January 23, 2018

DrugPatentWatch Database Preview

NALBUPHINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Nalbuphine Hydrochloride, and what generic alternatives are available?

Nalbuphine Hydrochloride is a drug marketed by Abbott, Abbvie, Barr, Hospira, and Igi Labs Inc. and is included in thirteen NDAs.

The generic ingredient in NALBUPHINE HYDROCHLORIDE is nalbuphine hydrochloride. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nalbuphine hydrochloride profile page.
Drug patent expirations by year for NALBUPHINE HYDROCHLORIDE
Pharmacology for NALBUPHINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for NALBUPHINE HYDROCHLORIDE

US Patents and Regulatory Information for NALBUPHINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070917-001 Feb 3, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070916-001 Feb 3, 1989 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 074471-002 Mar 19, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 072073-001 Apr 10, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070918-001 Feb 3, 1989 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 072075-001 Apr 10, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 020200-001 Mar 12, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 074471-001 Mar 19, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070915-001 Feb 3, 1989 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070914-001 Feb 3, 1989 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Mallinckrodt
Harvard Business School
US Army
Boehringer Ingelheim
Daiichi Sankyo
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot